Cannabis and HIV
Posted by Pozziepinoy on 6:11 PM
Cannabis,
also known as marihuana, marijuana, pot, grass, bhang, charas, ganja, weed, and
hashish is one of the so-called social or recreational drugs. It is
obtained from the flowering hemp plant Cannabis saliva.
Pharmacologically, the principal psychoactive constituent of cannabis is the cannabinoid tetrahydrocannabinol (THC). THC and other cannabinoids cross the blood brain barrier and act primarily on the cannabinoid 1 (CB1) receptors in the central nervous system affecting brain function. This results in alterations in mood, perception, consciousness, cognition and behavior. It also acts on the Cannabinoid 2 (CB2) receptors found primarily on cells of the immune system, gastrointestinal tract and peripheral nervous system. CB2 does not mediate any of the psychoactive effects mentioned above. There are three main types of cannabis products: herb (marijuana), resin (hashish) and oil (hash oil). Cannabis herb comprises the dried and crushed flower heads and surrounding leaves. It often contains up to 5 per cent THC content. However, sinsemilla, derived from the unfertilized female plant, can be much more potent. Cannabis resin can contain up to 20 per cent THC content. The most potent form of cannabis is cannabis oil, derived from the concentrated resin extract. It may contain more than 60 per cent THC content.
Pharmacologically, the principal psychoactive constituent of cannabis is the cannabinoid tetrahydrocannabinol (THC). THC and other cannabinoids cross the blood brain barrier and act primarily on the cannabinoid 1 (CB1) receptors in the central nervous system affecting brain function. This results in alterations in mood, perception, consciousness, cognition and behavior. It also acts on the Cannabinoid 2 (CB2) receptors found primarily on cells of the immune system, gastrointestinal tract and peripheral nervous system. CB2 does not mediate any of the psychoactive effects mentioned above. There are three main types of cannabis products: herb (marijuana), resin (hashish) and oil (hash oil). Cannabis herb comprises the dried and crushed flower heads and surrounding leaves. It often contains up to 5 per cent THC content. However, sinsemilla, derived from the unfertilized female plant, can be much more potent. Cannabis resin can contain up to 20 per cent THC content. The most potent form of cannabis is cannabis oil, derived from the concentrated resin extract. It may contain more than 60 per cent THC content.
How
is cannabis consumed?
It
can be smoked (e.g. bongs and joints), snorted as a snuff, eaten (e.g. brownies
and cannabutter), inhalation of vaporized herbal cannabis, drunk (e.g. tea and
milk), topically (e.g. balms, lotions, waxes and bars),
Are
there any medical uses for Cannabis relating to HIV infection?
This
is a difficult question to answer. There are difficulties in researching the
effects of cannabis. Many people who smoke cannabis also smoke tobacco.
And users of cannabis often mix it with tobacco. This can make it
difficult to know whether it is the tobacco, the cannabis, or both that has
caused a cancer. The amount of THC in cannabis also varies. Some of the
cannabis available today is much stronger than it was 20 years ago. These
versions contain more THC. Another difficulty researchers have is in
recruiting people who smoke cannabis into studies. Because cannabis is an
illegal drug in many countries, including the Philippines, people may be
reluctant to take part in research. And if they do agree to take part, they may
not say how much cannabis they actually smoke. Thus it is very difficult
to determine with certainty it’s long term effects or efficacy as a treatment
for any medical condition. In those countries in which it is used, it is
important to stress that medical marijuana is a doctor-prescribed treatment
and should only be used according to a doctor's instruction.
Medical
marijuana involves use of the cannabis extracts, called cannabinoids, secured
from legal vendors, in a doctor-prescribed way for specific purposes. Medical
use of marijuana can help relieve symptoms such as pain, glaucoma, migraine
headaches, nausea, and weight loss. However, due mostly to its legal status
in many countries, it has not been thoroughly tested to find out how it interacts
with many medications, foods, herbs, or supplements and therefore one should
never self medicate with it.
In
1996, a clinical trial in San Francisco found that people with HIV wasting
syndrome who used cannabis were more likely to put on weight. A study in 2007 found that HIV-positive users
of the drug had relief from the symptoms of peripheral neuropathy. The drug is
also widely used to relieve insomnia and the symptoms of anxiety and stress. It
is also used by people with multiple sclerosis as a muscle relaxant.
While
some studies have classified CB2 as a suppressor of CD4 cells and early trials
indicated that marijuana use was associated with progression to AIDS, more
recent analyses suggest that the drug isn’t associated with significant immune
suppression. In fact, both smoked marijuana and Marinol (dronabinol the
pharmaceutical formulation of THC used for loss of appetite associated with
weight loss in patients with AIDS), have been associated with increases in CD4
cell counts—along with a decrease in viral load—but only in short-term studies
and laboratory experiments. The CB2 receptor, is a protein located on the
surface of macrophages. CB2 is a binding site for substances called
cannabinoids, the primary active compounds of cannabis (marijuana), and it may
play a role in blocking inflammation in the CNS. To repeat, unlike its
counterpart, the CB1 receptor, which is found primarily on neurons in the
brain, CB2 does not mediate the psychoactive effects for which cannabis is
popularly known.
The
problem associated with its status as an illegal drug in any setting, including
a medical one, can be seen in recent reports onto the possible future used of
medical cannabis.
1) There has been much pharmacological interest in developing agents
that selectively target CB2. Ideally, these compounds would help limit
chronic inflammatory responses and would not bind to CB1. The most
promising compounds are those derived from THC (tetrahydrocannabinol), the main
active substance in cannabis. The development of such drugs, however,
hinges largely on knowing which cells harbor HIV. Earlier studies suggested
that T cells, central components of the immune system, are HIV reservoirs.
According to Ramirez and the study's senior investigator, Yuri Persidsky,
MD, PhD, Chair of the Department of Pathology and Laboratory Medicine at
TUSM, macrophages likely are the primary reservoir for HIV. They are
among the first cells to become infected following sexual transmission of the
virus, and they are found in every organ of the human body and circulate in the
blood. It is currently thought that macrophages may be responsible for
introducing HIV into the brain, ultimately initiating HIV-associated cognitive
decline. Using a non-clinical HIV macrophage cell model, they began by
treating the HIV-infected cells with one of three different synthetic
CB2-activating compounds. The cells were then sampled periodically to measure
the activity of an enzyme called reverse transcriptase, which is essential for
HIV replication. After seven days, the team found that all three compounds had
successfully attenuated HIV replication. The results suggest that
selective CB2 agonists could potentially be used in tandem with existing
antiretroviral drugs, opening the door to the generation of new drug therapies
for HIV/AIDS. The data also support the idea that the human immune system could
be leveraged to fight HIV infection. “Our study suggests that the body’s own
natural defenses can be made more powerful to fight some of the worst symptoms
of HIV,” Persidsky explained. He also noted that stimulating CB2
receptors in white blood cells could produce similar benefits against other
viral infections.
2) CR2 has also been found on a variety of immune system cells and is
present on CD4 cells in abundance. In effect, the mechanisms by which
the interactions between THC and the cannabinoid receptors alter CD4 cell
function remain unclear. One particular area of interest, though, is the
connection between CR2 and CXCR4, another receptor on immune system cells. For
example, CR2 activation blocks CXCR4 from directing the movement of certain
cells in the body (chemotaxis). CR2 also plays a role in moving white blood
cells out of bone marrow (egress), a role previously attributed largely to
CXCR4. The apparent “cross talk” between CR2 and CXCR4, therefore, led
the Mt. Sinai researchers—under the direction of Cristina Maria Costantino,
PhD—to explore whether stimulation of CR2 can block the way CXCR4 interacts
with a particular form of HIV: CXCR4-tropic virus. during the early years
of untreated HIV infection, HIV primarily targets—or is tropic for—cells with
the CCR5 receptor. As HIV disease progresses, however, approximately 50 percent
of people living with HIV see their virus develop preference for the CXCR4
receptor on CD4 cells. This particular form of the virus, research has shown,
is associated with rapid disease progression although it is unclear if the
emergence of CXCR4-tropic virus is a cause or an effect of immune
suppression. Costantinos test tube experiments proved encouraging.
Using a cannabinoid receptor agonist—a THC-like compound—her team found that
activation of CR2 inhibited CXCR4-tropic HIV infection. It did this, not by
altering the number of CXCR4 receptors on CD4 cells—this is a therapeutic
approach being explored by others—but rather by blocking the receptor’s
“signaling process” and interaction with HIV.
What
is the effect/risk of cannabis on an HIV+ person?
Like
all uncontrolled street drugs adulterants have frequently been found in
cannabis. Chalk (in the Netherlands) and glass particles (in the UK) have
been used to make cannabis appear to be higher quality. Increasing the weight of
hashish products in Germany with lead caused lead intoxication in at least 29
users In the Netherlands two chemical analogs of Viagra were found
in adulterated marijuana.
According
to both the "Talk to FRANK" website and the UKCIA website, Soap
Bar, "perhaps the most common type of hash in the UK", was found
"at worst" to contain turpentine, tranquilizers, boot polish, henna
and animal feces. One small study of five "soap-bar" samples
seized by UK Customs in 2001 found huge adulteration by many toxic substances,
including soil, glue, engine oil and animal feces. Even if the product
you are buying is free from adulterants or you grow your own, it is impossible
to be certain exactly how much of each particular compound within the product
you are self administering. The whole plant contains many compounds,
which have different actions in the human body. For example, studies show that
THC can raise anxiety and cause paranoia, while cannabidiol (CBD) may reduce
them. Components of the whole plant can have nearly opposite effects in the
human brain, so that one compound can change the effects of another.
Smoking
or eating whole marijuana can cause a number of mental and emotional effects,
including feelings of euphoria, short-term memory loss, difficulty in
completing complex tasks, changes in the perception of time and space,
sleepiness, anxiety, confusion, and inability to concentrate. A small but
significant percentage of people in medical studies didn’t like the mental
effects and withdrew from studies because of them. In studies, cannabinoids
have been linked with effects such as depression, paranoia, and hallucinations.
Those with a genetic vulnerability to mental illness may have more
serious mental and emotional effects from marijuana use such as schizophrenia,
psychosis, depersonalization disorder and depression.
Physical
side effects include low blood pressure, fast heartbeat, dizziness, slow
reaction time, and heart palpitations. Instances of serious heart problems are
very rare.
Many
researchers agree that marijuana smoke contains known carcinogens, or chemicals
that can cause cancer much like those in tobacco smoke. Studies have shown
changes in the linings of the breathing passages in marijuana smokers.
But results of epidemiologic studies of marijuana and cancer risk have
been inconsistent, and most recent epidemiologic studies have not found a
substantial effect on cancer risk. It’s possible that some of these
differences are due to the fact that most marijuana smokers don’t smoke as much
or as often as tobacco smokers. Effects might be more evident in heavy
marijuana smokers.
Some
researchers also caution that these studies are difficult to conduct, as some
people may not admit to illegal habits such as smoking marijuana, and that
negative results should not be interpreted as convincing evidence of safety.
Most researchers believe herbal marijuana contains toxins and carcinogens
that lead to increased risk of respiratory diseases and cancer and therefore
recommend other methods of consumption of medical marijuana besides
smoking. It should be noted that people inhale cannabis smoke for longer
than cigarette smoke. This is to get the full effect of the cannabis. But it
means that the smoke is in contact with the lungs for longer. Various
researchers have found that smoking marijuana may cause lung disease and
increase the risk of cancer of the lungs, mouth, tongue and testicles.
It
is not known how cannabis reacts with ARVs. A small American study found
that cannabis use did not impact on the effectiveness of the protease inhibitor
Indinavir even though the drugs use the same mechanism to pass through the
body.
Like
any mood and consciousness-altering drug, cannabis may have an impact on a HIV+
persons ability to adhere to their ARV and other medication
schedules. People planning to use cannabis, or any other
recreational drug, and thus risk arrest as well as the unwanted side effects of
the drug, may need to develop strategies to help them take their medication at
the right time and in the right way.
Overwhelmingly
the evidence suggests that, until medical marijuana is available as a
controlled substance under that supervision of a qualified Medical
Practitioner, its use should be avoided.
I
hope people have found this post useful.
Credits:
Get
tested, stay healthy and, if you’re HIV+, compliant with your ARV regimen,
Malcolm
Brown.
International Contributor
"WE
ARE ALL IN THIS TOGETHER.
NO PLHIV is
alone with his or her struggle with HIV!"
-Pozziepinoy-
If you have
comments or questions, please click this link:
© Copyright. All Rights
Reserved by Pozziepinoy 2012
Credits:
Image by FreeDigitalPhotos.net
Tags: HIV Manila, HIV Philippines,
AIDS Manila, AIDS Philippines, HIV/AIDS Manila, HIV/AIDS Philippines